Back

Effect of SGLT2 inhibitors on left atrial strain in patients of acute coronary syndrome and diabetes mellitus

29 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes beyond obstruction: spontaneous coronary artery dissection, inflammation, and vulnerable plaque Left Ventricular Remodelling ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Roopali Reddy Dandu

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow (India)

6 More presentations in this session

Presentation thumbnail
Circadian patterns of symptom onset in spontaneous coronary artery dissection
Miss J. Al-Gully (Leiden University Medical Center, NL)
Abstract Slides
Presentation thumbnail
Dynamic and non-linear changes in lipoprotein(a) during acute coronary syndrome
Doctor S. Fujioka (Osaka, JP)
Abstract Slides
Presentation thumbnail
Transcriptomic signature of trained immunity associates with the extent of coronary artery disease in acute coronary syndrome
Doctor J. Chai (Oxford, GB)
Abstract Slides
Presentation thumbnail
Impact of fibromuscular dysplasia on early and late clinical outcome in patients with spontaneous coronary artery dissection
Doctor D. Wussler (Basel, CH)
Abstract Slides
Presentation thumbnail
Persistent inflammation after acute coronary syndrome identifies systemic vulnerability in a low inflammatory Japanese population: insights from the clinical deep data accumulation system (CLIDAS)
Doctor T. Tabuchi (JP)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes beyond obstruction: spontaneous coronary artery dissection, inflammation, and vulnerable plaque

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial strain is improved with addition vs. no addition of SGLT2 inhibitor to background heart failure pharmacotherapy among patients with HFrEF: a prospective cohort study with 3-month follow-up
21 May 2023
thumbnail
Congress Presentation
Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis
27 August 2021
thumbnail
Webinar
Early initiation of SGLT-2 inhibitors after acute decompensated heart failure
26 October 2022
thumbnail
Congress Presentation
Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources